1. Home
  2. OLMA vs BRT Comparison

OLMA vs BRT Comparison

Compare OLMA & BRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OLMA
  • BRT
  • Stock Information
  • Founded
  • OLMA 2006
  • BRT 1972
  • Country
  • OLMA United States
  • BRT United States
  • Employees
  • OLMA N/A
  • BRT N/A
  • Industry
  • OLMA Biotechnology: Pharmaceutical Preparations
  • BRT Real Estate Investment Trusts
  • Sector
  • OLMA Health Care
  • BRT Real Estate
  • Exchange
  • OLMA Nasdaq
  • BRT Nasdaq
  • Market Cap
  • OLMA 289.0M
  • BRT 280.9M
  • IPO Year
  • OLMA 2020
  • BRT N/A
  • Fundamental
  • Price
  • OLMA $4.67
  • BRT $15.52
  • Analyst Decision
  • OLMA Strong Buy
  • BRT Strong Buy
  • Analyst Count
  • OLMA 3
  • BRT 3
  • Target Price
  • OLMA $27.67
  • BRT $21.83
  • AVG Volume (30 Days)
  • OLMA 902.4K
  • BRT 40.3K
  • Earning Date
  • OLMA 05-16-2025
  • BRT 05-20-2025
  • Dividend Yield
  • OLMA N/A
  • BRT 6.46%
  • EPS Growth
  • OLMA N/A
  • BRT N/A
  • EPS
  • OLMA N/A
  • BRT N/A
  • Revenue
  • OLMA N/A
  • BRT $97,274,000.00
  • Revenue This Year
  • OLMA N/A
  • BRT $0.73
  • Revenue Next Year
  • OLMA N/A
  • BRT $5.64
  • P/E Ratio
  • OLMA N/A
  • BRT N/A
  • Revenue Growth
  • OLMA N/A
  • BRT 1.65
  • 52 Week Low
  • OLMA $2.86
  • BRT $14.61
  • 52 Week High
  • OLMA $16.62
  • BRT $20.22
  • Technical
  • Relative Strength Index (RSI)
  • OLMA 50.50
  • BRT 40.29
  • Support Level
  • OLMA $4.35
  • BRT $15.16
  • Resistance Level
  • OLMA $5.74
  • BRT $16.42
  • Average True Range (ATR)
  • OLMA 0.40
  • BRT 0.49
  • MACD
  • OLMA -0.02
  • BRT 0.05
  • Stochastic Oscillator
  • OLMA 25.26
  • BRT 13.49

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

About BRT BRT Apartments Corp. (MD)

BRT Apartments Corp is a real estate investment trust company. The company is focused on the ownership, operation, and development of multi-family properties. BRT also owns and operates other real estate assets. All of the Company's assets are comprised of multi-family real estate assets generally leased to tenants on a one-year basis.

Share on Social Networks: